Exane Derivatives’s SLB Ltd SLB Stock Holding History
Bought
Maintained
Sold
Other funds holding SLB
Exane Derivatives's SLB Position: Q2 2022 in Review
Exane Derivatives reduced its SLB Ltd (SLB) stake by 49% in Q2 2022, selling an estimated $745K and leaving 18,872 shares worth $675K. The position accounts for 0.39% of the portfolio, ranked #59.
Exane Derivatives first reported a position in SLB in Q2 2015 and has held it in 18 quarters since. The position peaked at $4.32M in Q1 2019. 1,263 funds tracked by Wall St. Rank hold SLB as of Q2 2022.
- Exane Derivatives held 18,872 shares of SLB Ltd worth $675K as of Q2 2022.
- Exane Derivatives sold 17,866 SLB Ltd shares in Q2 2022, an estimated $745K.
- SLB Ltd made up 0.39% of Exane Derivatives's portfolio in Q2 2022, its #59 holding.
- Exane Derivatives first reported a position in SLB Ltd in Q2 2015 and has held it in 18 quarters since.
- Exane Derivatives's SLB Ltd position peaked at $4.32M in Q1 2019.
- 1,263 funds tracked by Wall St. Rank held SLB Ltd as of Q2 2022.
Based on Exane Derivatives's 13F filing for Q2 2022, filed 12 Jul 2022.